(Q33669280)

28 July 2017

title

CD40mAb adjuvant induces a rapid antibody response that may be beneficial in post-exposure prophylaxis (English)

1 reference

post-exposure prophylaxis

28 July 2017

main subject

1 reference

inferred from title

author name string

Vijay Ns Bhagawati-Prasad

1

1 reference

28 July 2017

Evy De Leenheer

2

1 reference

28 July 2017

Nadine P Keefe

3

1 reference

28 July 2017

Lorna A Ryan

4

1 reference

28 July 2017

Jennifer Carlring

5

1 reference

28 July 2017

Andrew W Heath

6

1 reference

28 July 2017

publication date

4 February 2010

1 reference

Journal of immune based therapies and vaccines

28 July 2017

published in

1 reference

28 July 2017

volume

8

1 reference

28 July 2017

page(s)

1

1 reference

https://scigraph.springernature.com/pub.10.1186/1476-8518-8-1

28 July 2017

exact match

0 references

cites work

Novel vaccines to human rabies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824643

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824643

Immunology of TLR-independent vaccine adjuvants

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824643

Vaccine adjuvants: the dream becomes real

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824643

Liposomal co-entrapment of CD40mAb induces enhanced IgG responses against bacterial polysaccharide and protein

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824643

Nanoparticles and microparticles as vaccine-delivery systems

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824643

CD40-mediated enhancement of immune responses against three forms of influenza vaccine.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824643

Prospect of targeting the CD40 pathway for cancer therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824643

Vector prime/protein boost vaccine that overcomes defects acquired during aging and cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824643

Co-stimulatory agonists as immunological adjuvants

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824643

Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824643

Anthrax as a biological weapon, 2002: updated recommendations for management

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824643

Antibodies to murine CD40 stimulate normal B lymphocytes but inhibit proliferation of B lymphoma cells.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824643

Very small size proteoliposomes derived from Neisseria meningitidis: An effective adjuvant for generation of CTL responses to peptide and protein antigens

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824643

CD40 antibody as an adjuvant induces enhanced T cell responses.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824643

Long-term protective effect of post-exposure Havrix administration during viral hepatitis Type A outbreaks

30 October 2018

1 reference

12 December 2020

CD40 antibody as a potent immunological adjuvant: CD40 antibody provides the CD40 signal to B cells, but does not substitute for T cell help in responses to TD antigens

1 reference

12 December 2020

Enhancement of T cell-independent immune responses in vivo by CD40 antibodies

1 reference

12 December 2020

Postexposure varicella vaccination in siblings of children with active varicella

1 reference

12 December 2020

A potent adjuvant effect of CD40 antibody attached to antigen

1 reference

12 December 2020

Functional activity of CD40 antibodies correlates to the position of binding relative to CD154

1 reference

12 December 2020

Postexposure effectiveness of varicella vaccine

1 reference

12 December 2020

Identifiers

DOI

10.1186/1476-8518-8-1

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference